Gradient Investments’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-268
| Closed | -$17K | – | 1127 |
|
|
2019
Q4 | $17K | Hold |
268
| – | – | ﹤0.01% | 589 |
|
|
2019
Q3 | $16K | Hold |
268
| – | – | ﹤0.01% | 556 |
|
|
2019
Q2 | $23K | Hold |
268
| – | – | ﹤0.01% | 494 |
|
|
2019
Q1 | $26K | Hold |
268
| – | – | ﹤0.01% | 412 |
|
|
2018
Q4 | $19K | Hold |
268
| – | – | ﹤0.01% | 457 |
|
|
2018
Q3 | $23K | Hold |
268
| – | – | ﹤0.01% | 468 |
|
|
2018
Q2 | $31K | Hold |
268
| – | – | ﹤0.01% | 409 |
|
|
2018
Q1 | $22K | Hold |
268
| – | – | ﹤0.01% | 457 |
|
|
2017
Q4 | $16K | Buy |
+268
| New | +$16K | ﹤0.01% | 507 |
|
|
2017
Q3 | – | Sell |
-268
| Closed | -$10K | – | 367 |
|
|
2017
Q2 | $10K | Hold |
268
| – | – | ﹤0.01% | 479 |
|
|
2017
Q1 | $8K | Buy |
+268
| New | +$8K | ﹤0.01% | 541 |
|